7 Ron Baron Novo Nordisk Trades
Ron Baron's position in Novo Nordisk is currently worth $1.97 Million. That's 0.01% of their equity portfolio (254th largest holding). The first Novo Nordisk trade was made in Q2 2022. Since then Ron Baron bought shares one more times and sold shares on five occasions. The investor's estimated purchase price is $2.97 Million, resulting in a loss of 33%.
Avg closing price
Price range
Sold 11.7% shares (-3.98 Thousand shares)
Q4 2024
Avg closing price
$106.90
Price range
$85.00
-
$120.04
Sold 26.1% shares (-12 Thousand shares)
Q3 2024
Avg closing price
$133.54
Price range
$119.07
-
$145.42
Sold 11.9% shares (-6.2 Thousand shares)
Q2 2024
Avg closing price
$132.51
Price range
$122.71
-
$146.91
Sold 5.6% shares (-3.07 Thousand shares)
Q1 2024
Avg closing price
$119.04
Price range
$102.11
-
$135.92
New holding (+55.2 Thousand shares)
Q4 2023
Avg closing price
$98.89
Price range
$87.78
-
$105.45
Sold -106 Thousand shares
Q3 2022
Avg closing price
$107.14
Price range
$95.28
-
$116.93
New holding (+106 Thousand shares)
Q2 2022
Avg closing price
$110.98
Price range
$103.24
-
$121.81
News about Novo Nordisk - ADR and Ron Baron
Is Novo Nordisk (NVO) a Smart Long-Term Investment?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. I...
Is Novo Nordisk (NVO) a Smart Long-Term Investment?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.